BRIEF published on 08/15/2024 at 19:00, 1 year 11 months ago CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product International Expansion Medical Cannabis CannapharmaRx Cannabis Production Purchase Orders
PRESS RELEASE published on 08/15/2024 at 18:55, 1 year 11 months ago CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product CannaPharmaRx, Inc. receives 600KG cannabis orders from Cantek Holdings, further solidifying its position in the cannabis market internationally. Continues high-quality production at Cremona facility International Markets CannapharmaRx Cantek Holdings Cannabis Orders Cremona Facility
BRIEF published on 06/28/2024 at 09:05, 2 years ago CannaPharmaRx Reports Q1 2024 Financial Performance Financial Results Revenue Operating Expenses Licenses Strategic Agreements
PRESS RELEASE published on 06/28/2024 at 09:00, 2 years ago Q1 2024 Financial Results CannaPharmaRx reports Q1 2024 financial results with revenue commencing. The company anticipates accelerated growth, international expansion, and strategic partnerships Financial Results Revenue Growth Q1 2024 CannapharmaRx
BRIEF published on 05/20/2024 at 19:50, 2 years 2 months ago CannaPharmaRx to Host Investor Conference Call on May 21, 2024 Investor Conference Call Financial Update Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 19:45, 2 years 2 months ago CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. (OTC PINK:CPMD) will host an investor conference call on May 21, 2024, at 1PM Eastern time to provide updates on financials, products, distribution, and expansion Investor Conference Call Financial Update CannapharmaRx Cannabis Production CPMD
BRIEF published on 05/20/2024 at 18:35, 2 years 2 months ago CannaPharmaRx to Host Investor Conference Call Investor Conference Financial Update CannapharmaRx Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 18:30, 2 years 2 months ago CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. to hold investor conference call on May 21, 2024, providing updates on financials, products, orders, and forecasts. Visit www.cannapharmarx.com for details Investor Conference Call Financial Update CannapharmaRx Cannabis Production Forecasted Revenues
BRIEF published on 04/02/2024 at 12:05, 2 years 3 months ago CannapharmaRx Successfully Repays Convertible Notes to Strengthen Position Convertible Notes Debt Repayment Shareholder Interests CannapharmaRx Cannabis Production
PRESS RELEASE published on 04/02/2024 at 12:00, 2 years 3 months ago CannapharmaRx Pays Off Convertible Notes CannapharmaRx, Inc. announces the extinguishment of convertible notes to avoid stock dilution and strengthen the company. CEO Dean Medwid discusses the positive impact on future growth and valuation Convertible Notes Future Growth CannapharmaRx Stock Dilution CEO Dean Medwid
Published on 07/22/2026 at 15:00, 8 hours 13 minutes ago Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 8 hours 13 minutes ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:35, 8 hours 38 minutes ago Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 8 hours 43 minutes ago As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Published on 07/22/2026 at 22:20, 52 minutes ago Quantinuum Appoints Chief Legal Officer and Chief People Officer
Published on 07/22/2026 at 21:01, 2 hours 11 minutes ago EQS-Adhoc: Correction of a release from 22/07/2026, 20:08 CET/CEST - FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Published on 07/22/2026 at 20:44, 2 hours 29 minutes ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on July 22, 2026
Published on 07/22/2026 at 20:08, 3 hours 4 minutes ago EQS-Adhoc: FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Published on 07/22/2026 at 18:19, 4 hours 54 minutes ago Covivio successfully places €500 million of 7-year European Green Bonds
Published on 07/22/2026 at 17:45, 5 hours 28 minutes ago Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Published on 07/22/2026 at 17:40, 5 hours 33 minutes ago Report on share repurchases from 15 to 21 July 2026
Published on 07/22/2026 at 08:03, 15 hours 10 minutes ago Availability of the 2026 Interim Results Report
Published on 07/22/2026 at 08:00, 15 hours 13 minutes ago Neoen launches construction of Narrogin Wind Farm in Western Australia after signing PPA with Synergy
